Financials

  • Market Capitalization 15.47 M
  • Employee 6
  • Founded 2009
  • CEO N/A
  • Website www.kalarx.com
  • Headquarter Delaware, United States
  • FIGI BBG001J2MVT8
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-0.17
ratio cours/chiffre d'affaires

Related tickers

#NomPrix24h %7 jours %1M %1 an %Cap Boursière7 Derniers Jours
4651
TPST
Tempest Therapeutics, Inc. - Common Stock
1.08 USD0.00%+6.93%+27.06%-54.81%15.99 M USD
4662
HIND
Vyome Holdings, Inc. - Common Stock
2.21 USD+2.79%0.00%+11.06%-76.39%15.51 M USD
4671
ADIL
Adial Pharmaceuticals, Inc - Common Stock
5.69 USD-4.21%-4.37%+98.26%+1358.97%14.94 M USD
4682
AEON
AEON Biopharma, Inc. Class A Common Stock
0.29 USD+16.00%+45.00%+11.54%-72.12%14.47 M USD

Nouvelles